You are here

Structural & Congenital Heart Disease

 

A recent article in Cardiovascular Business summarized the lack of quality research on surgeries for children with congenital heart disease. Finding participants isn't the problem; study design and execution are at fault.

New-generation devices have made transcatheter aortic valve replacements (TAVRs) easier to perform in patients with pure native aortic regurgitation (AR), suggests a study published in the Journal of the American College of Cardiology.

Infant deaths from critical congenital heart disease (CCHD) declined by 33.4 percent in eight states that mandated pulse oximetry screening for newborns, according to a study published online Dec. 5 in JAMA.

Multidetector computed tomography (CT) could play a pivotal role in improving the outcomes of transcatheter aortic valve replacement (TAVR) procedures, research presented at the 103rd annual RSNA symposium suggests.

The mortality risk associated with moderate to severe PVR was consistent with previous studies, wrote lead author Philippe Pibarot, DVM, PhD, and colleagues, but the rate of moderate or worse PVR dropped threefold when compared to previous SAPIEN valves.

 

Recent Headlines

Researchers must better evaluate surgical options for congenital heart disease

A recent article in Cardiovascular Business summarized the lack of quality research on surgeries for children with congenital heart disease. Finding participants isn't the problem; study design and execution are at fault.

New TAVR devices linked to improved outcomes in patients with aortic regurgitation

New-generation devices have made transcatheter aortic valve replacements (TAVRs) easier to perform in patients with pure native aortic regurgitation (AR), suggests a study published in the Journal of the American College of Cardiology.

Infant CCHD deaths cut by 33% after mandatory pulse oximetry testing

Infant deaths from critical congenital heart disease (CCHD) declined by 33.4 percent in eight states that mandated pulse oximetry screening for newborns, according to a study published online Dec. 5 in JAMA.

Boston Scientific delays plans to reintroduce LOTUS valve to European market

Plans to reintroduce the troubled LOTUS Edge Aortic Valve System into the European market have stalled, Boston Scientific reported Tuesday.

CT imaging key to accurate measurements, successful TAVR

Multidetector computed tomography (CT) could play a pivotal role in improving the outcomes of transcatheter aortic valve replacement (TAVR) procedures, research presented at the 103rd annual RSNA symposium suggests.

Paravalvular regurgitation rates slashed with SAPIEN 3 heart valves

The mortality risk associated with moderate to severe PVR was consistent with previous studies, wrote lead author Philippe Pibarot, DVM, PhD, and colleagues, but the rate of moderate or worse PVR dropped threefold when compared to previous SAPIEN valves.

Pediatric heart patients let down by scarcity of quality research

Children suffering from congenital heart disease worldwide are being let down by a paucity of research on their conditions, a review published in the European Journal of Cardio-Thoracic Surgery reports.

Proving the cost-effectiveness of TAVR

When it comes to TAVR, what is good for patients is good for economics too. Or more specifically, what is good for Medicare patients with severe aortic stenosis at intermediate risk for surgery is good for reductions in U.S healthcare costs. The amount depends on where you live, with CMS reimbursing much higher on the East and West Coasts versus the center of the country with valve costs remaining the same.

Mechanical heart valves associated with greater long-term survival for most age groups

Patients who received a mechanical prosthesis for surgical replacement of aortic or mitral valves derived a significant long-term survival benefit versus those who received a biologic prosthesis, according to a study in the New England Journal of Medicine.

Half of U.S. valve hospitals misclassified as low- or high-performing

Nearly half of all valve hospitals in the U.S. are misclassified as either low- or high-performing, according to research published in JAMA Cardiology—but that problem might have a simple fix.

Pages